secwatch.observer — SEC 8-K summary
======================================

Issuer:     NextCure, Inc. (NXTC)
CIK:        0001661059
Form:       8-K
Filed at:   2024-12-05T23:59:59+00:00
Accession:  0001558370-24-016026
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NextCure files IND for product candidate LNCB74
-----------------------------------------------

- Filed Investigational New Drug application with FDA for LNCB74.
- Updated corporate presentation to reflect the IND filing.
- Company engaging with investment community starting December 5, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661059/000155837024016026/0001558370-24-016026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661059/000155837024016026/nxtc-20241205x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-016026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer